<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.ijidonline.com//inpress?rss=yes"><title>International Journal of Infectious Diseases - Articles in Press</title><description>International Journal of Infectious Diseases RSS feed: Articles in Press.    
 
 The International Journal of Infectious Diseases 
  (IJID) is published monthly by the International Society for Infectious 
Diseases. This Journal is now only available online.  IJID welcomes manuscripts in the following categories: epidemiology, clinical diagnosis, 
treatment and control of infectious diseases with particular emphasis placed on those diseases that are most common in less-developed 
countries.

 
 
 
 IJID 
  publishes original clinical and laboratory-based research, together with reports of clinical trials, 
reviews and some case reports.

 
 
 Please noted as of December 2010 the International Journal of Infectious Diseases will be published 
online only. 
   </description><link>http://www.ijidonline.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 International Society for Infectious Diseases. Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:issn>1201-9712</prism:issn><prism:publicationDate>2012-02-02</prism:publicationDate><prism:copyright> © 2012 International Society for Infectious Diseases. Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971212000161/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS120197121200015X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971212000185/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971212000033/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971212000070/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971212000021/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002499/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002505/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002463/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002475/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002487/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002451/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002396/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS120197121100244X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002438/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002414/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002372/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971211002207/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ijidonline.com/article/PIIS1201971204000438/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.ijidonline.com/article/PIIS1201971212000161/abstract?rss=yes"><title>Ultrasonographic evaluation of knee joints in patients with Lyme disease - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971212000161/abstract?rss=yes</link><description>Summary: Objective: The aim of this study was to evaluate the ultrasonographic images of patients with chronic knee pain and serologic features of Lyme disease.Methods: Seventy-six patients hospitalized in The Department of Infectious Diseases and Neuroinfections of the Medical University in Białystok, Poland were included in the study. Patients were divided into two groups: (1) the Lyme disease group included patients with pain in one or both knees and anti-Borrelia burgdorferi antibodies with symptoms lasting for over 6 months; (2) the control group included patients suffering from pain in one or both knees for over 6 months, but for whom B. burgdorferi infection was excluded.Results: The most frequent ultrasonographic finding in the Lyme disease group was effusion, and its frequency was significantly higher than in the control group. No patient in the control group presented with synovitis or cartilage damage, while these were quite frequent findings in the Lyme disease group. Baker's cysts were more frequent in the Lyme disease group, but this was statistically non-significant.Conclusions: Ultrasonography may be useful in following the sequelae of Lyme disease. The abnormalities found in Lyme disease patients are non-specific and ultrasonography is not useful in the differential diagnosis.</description><dc:title>Ultrasonographic evaluation of knee joints in patients with Lyme disease - Corrected Proof</dc:title><dc:creator>Piotr Czupryna, Anna Moniuszko, Anna Czeczuga, Sławomir Pancewicz, Joanna Zajkowska</dc:creator><dc:identifier>10.1016/j.ijid.2011.12.004</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-02-02</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-02-02</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS120197121200015X/abstract?rss=yes"><title>Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS120197121200015X/abstract?rss=yes</link><description>Summary: Background: Traditional regimens for the treatment of brucellosis are associated with significant relapse rates. The aim of this study was to compare the efficacy of ofloxacin plus rifampin (OFX–RIF) versus doxycycline plus streptomycin (DOX–STR) and doxycycline plus rifampin (DOX–RIF) regimens in the treatment of brucellosis.Methods: Two hundred and nineteen patients with brucellosis were enrolled in a randomized clinical trial; 28 cases were withdrawn because they did not attend the follow-up. Out of 191 patients with brucellosis, 64 received OFX–RIF, 62 received DOX–RIF, and 65 patients received DOX–STR regimens. All patients were assessed during the period of therapy in the second, fourth, and sixth weeks by clinical course and were also followed up clinically and serologically for 6 months after the cessation of therapy.Results: The highest clinical response (95.4%) was observed in the DOX–STR group (p=0.009). The results of multivariate analysis indicate that treatment with DOX–STR had the least therapeutic failures among the three groups (p=0.033). Adverse reactions were seen in 16.8% of patients, but there was no significant difference among the three groups (p=0.613). The lowest relapse rate (4.6%) was observed in the DOX–STR group (p=0.109).Conclusions: We conclude that the DOX–STR combination should remain the first-line regimen for the treatment of brucellosis in our region; we recommend DOX–RIF and OFX–RIF combinations as the second-line regimens.</description><dc:title>Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial - Corrected Proof</dc:title><dc:creator>Seyyed Hamid Hashemi, Latif Gachkar, Fariba Keramat, Mojgan Mamani, Mehrdad Hajilooi, Alireza Janbakhsh, Mohammad Mehdi Majzoobi, Hossein Mahjub</dc:creator><dc:identifier>10.1016/j.ijid.2011.12.003</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-02-01</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-02-01</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971212000185/abstract?rss=yes"><title>Betel quid use in relation to infectious disease outcomes in Cambodia - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971212000185/abstract?rss=yes</link><description>Summary: Objectives: The habitual chewing of betel quid (areca nut, betel leaf, tobacco) is estimated to occur among 600 million persons in Asia and the Asia-Pacific Region. Emerging data from rural Asia indicate that the betel quid is part of traditional medicine practices that promote its use for a wide range of ailments, including infectious disease. In the present study, we examined the association between betel quid, traditional medicine, and infectious disease outcomes.Methods: For the purpose of a nationwide, interviewer-administered, cross-sectional survey of tobacco use (including betel quid), we conducted a stratified three-stage cluster sampling of 13 988 adults aged 18 years and older from all provinces of Cambodia.Results: We found an association between the intensity of betel quid use and HIV/AIDS (odds ratio (OR) 2.06, 95% CI 1.09–3.89), dengue fever (OR 2.40, 95% CI 1.55–2.72), tuberculosis (OR 1.50, 95% CI 0.96–2.36), and typhoid (OR 1.48, 95% CI 0.95–2.30). These associations were even stronger in women – the primary users of betel quid in Cambodia. Multivariable analyses that controlled for age, gender, income, education, urban versus rural dwelling, receiving care from traditional medicine practitioners, and cigarette smoking did not alter the betel quid–infectious disease association.Conclusions: Our findings raise the possibility of a role of betel quid use in the transmission of infectious disease through pathways such as immunosuppression, oral route of entry for a pathogen (i.e., through injury to the oral mucosa), and contamination (i.e., fecal–oral) of the betel quid ingredients.</description><dc:title>Betel quid use in relation to infectious disease outcomes in Cambodia - Corrected Proof</dc:title><dc:creator>Pramil N. Singh, Zuhair Natto, Daravuth Yel, Jayakaran Job, Synnove Knutsen</dc:creator><dc:identifier>10.1016/j.ijid.2011.12.006</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-02-01</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-02-01</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971212000033/abstract?rss=yes"><title>A sandfly fever virus outbreak in the East Mediterranean region of Turkey - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971212000033/abstract?rss=yes</link><description>Summary: Objectives: To report a sandfly fever virus (SFV) outbreak that occurred in Kahramanmaras Province, Turkey.Methods: We investigated the cases of 40 patients with a history of sandfly bites and with clinical findings, who were referred to our emergency service between July and August 2010. Serum samples of 19 patients were selected and analyzed using a commercial mosaic immunofluorescence test (IFT) to detect IgM and IgG antibodies against SFV.Results: Sandfly fever was diagnosed in nine patients. All cases had a history of fly bite, and the clinical findings included fever, headache, myalgia, conjunctival hyperemia, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. In two patients, the diagnosis was confirmed by real-time PCR as sandfly Sicilian virus (SFSV). Laboratory findings in the patients included leukopenia, thrombocytopenia, and elevated levels of aspartate aminotransferase, alanine aminotransferase, creatine kinase, and C-reactive protein. All patients made a complete recovery with symptomatic treatment.Conclusions: SFV is endemic in the Mediterranean Basin and data regarding SFV activity in Turkey are limited. This is the first report of an SFV outbreak from Kahramanmaras Province, Turkey, and provides information on epidemiological, clinical, and laboratory aspects of SFV infections.</description><dc:title>A sandfly fever virus outbreak in the East Mediterranean region of Turkey - Corrected Proof</dc:title><dc:creator>Selma Guler, Ekrem Guler, Dilek Yagci Caglayik, Omer Faruk Kokoglu, Hasan Ucmak, Fatma Bayrakdar, Yavuz Uyar</dc:creator><dc:identifier>10.1016/j.ijid.2011.12.001</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-31</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-31</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971212000070/abstract?rss=yes"><title>Macrophage activation syndrome following Acinetobacter baumannii sepsis - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971212000070/abstract?rss=yes</link><description>Summary: Macrophage activation syndrome (MAS) is a systemic disorder with a high mortality, commonly associated with rheumatological conditions, but which can also occur as a complication of several infections. Here we present a case of MAS following Acinetobacter baumannii sepsis. Early institution of therapy with prednisolone, cyclosporine, colistin, and polymyxin resulted in a prompt clinical recovery. There are very few reported cases of Acinetobacter-related MAS that have been successfully treated.</description><dc:title>Macrophage activation syndrome following Acinetobacter baumannii sepsis - Corrected Proof</dc:title><dc:creator>Teny Mathew John, Ceena N. Jacob, Cherian C. Ittycheria, Amrutha M. George, Amith G. Jacob, Saji Subramaniyam, Jabbar Puthiyaveettil, R. Jayaprakash</dc:creator><dc:identifier>10.1016/j.ijid.2011.12.002</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-30</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-30</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971212000021/abstract?rss=yes"><title>Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010 - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971212000021/abstract?rss=yes</link><description>Summary: Background: In a previous study covering the period 1998–2004, we estimated the incidence of invasive pneumococcal disease (IPD) in Singapore to be 13.6 per 105 children aged &lt;5 years, and determined that the 7-valent pneumococcal conjugate vaccine (PCV-7) would provide 78.1% serotype coverage for children aged &lt;5 years. In the present study we sought to determine whether incidence and serotype trends have changed and to estimate pneumococcal vaccine coverage.Methods: We retrospectively reviewed IPD cases from 2005 to 2010 and calculated separate serotype proportions and population-based incidence rates for 2005–2007 (early PCV period) and 2008–2010 (late PCV period). PCV-7 coverage was obtained from the National Immunisation Registry, and patients with PCV-7 vaccine-type IPD (VT IPD) and non-vaccine-type IPD (non-VT IPD) were compared.Results: One hundred and eighteen patients, with a mean age of 46 months, were identified during 2005–2010. The incidence rate of IPD increased to 14.8 (for 2005–2007) and 15.2 (for 2008–2010) per 105 children &lt;5 years, despite a gradual increase in PCV-7 coverage to approximately 45% of the birth cohort receiving one or more doses of PCV-7. Although IPD due to serotypes 6B and 19A increased, there was a concomitant reduction in other serotypes. Coverage by PCV-7 progressively declined from 78.6% in 2005–2007 to 64.4% in 2008–2010 for children aged &lt;5 years.Conclusions: Although population coverage with PCV-7 has risen, it remains suboptimal and the incidence of IPD remains unchanged. Furthermore, significant serotype changes (especially increases in 19A) have occurred. We need to adopt newer PCVs with broader serotype coverage and increase the number of children vaccinated as a matter of urgency.</description><dc:title>Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010 - Corrected Proof</dc:title><dc:creator>Koh Cheng Thoon, Chia Yin Chong, Nancy Wen Sim Tee</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.014</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-27</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-27</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002499/abstract?rss=yes"><title>Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001–2002 - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002499/abstract?rss=yes</link><description>Summary: Objectives: Recognizing the uniqueness of secondary dengue virus (DENV)-1/3 dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) cases at an interval of 24 years, we sought to estimate DENV infections as well as the ratios between mild disease and DHF/DSS by DENV infection sequence in Playa District (Havana, Cuba) during the 2001–2002 outbreak of dengue virus type 3 (DENV-3).Methods: A retrospective seroepidemiological study was conducted in 2003 in Playa District. Blood samples were collected from a 1% random sample of residents and were studied for the prevalence of dengue neutralizing antibodies.Results: DENV-3 was found to have infected 7.2% (95% confidence interval (95% CI) 6.0–8.4%) of susceptible individuals (the entire cohort), the majority of whom experienced silent infections. Virtually every individual who had a secondary infection in the sequence DENV-1 then DENV-3 became ill, with a ratio of severe to mild cases of 1:35 (95% CI 1:67–1:23). Secondary infections in the sequence DENV-2/3 were less pathogenic than DENV-1/3. Mild disease accompanying secondary DENV2/3 occurred at a ratio of 1:4.49 infections (95% CI 1:5.77–1:3.42) secondary infections.Conclusions: The results obtained highlight the role of the infecting serotype and also the sequence of the viral infection in the clinical outcome of a dengue infection.</description><dc:title>Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001–2002 - Corrected Proof</dc:title><dc:creator>Maria G. Guzman, Angel Alvarez, Susana Vazquez, Mayling Alvarez, Delfina Rosario, Otto Pelaez, Guillermo Cruz, Rosmari Rodriguez, Alequis Pavon, Annia Gonzalez, Luis Morier, Dydie Ruiz, Gustavo Kouri, Scott B. Halstead</dc:creator><dc:identifier>10.1016/j.ijid.2011.09.026</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-25</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-25</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002505/abstract?rss=yes"><title>Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002505/abstract?rss=yes</link><description>Summary: Objectives: To identify the role of single nucleotide polymorphisms (SNPs) of the tumor necrosis factor (TNF) gene in the natural course of 2009 influenza A H1N1 virus infection.Methods: Genomic DNA was isolated from 109 patients with an H1N1 infection and from 108 healthy volunteers. SNPs of the TNF gene were assessed after electrophoresis of the digested PCR products by restriction enzymes.Results: The frequency of the −238 A allele was significantly greater among patients than among controls. Viral pneumonia developed in 20 of 96 non-carriers of at least one −238 A allele (20.8%) and in seven of 13 carriers of at least one −238 A allele (53.8%, p=0.016). Logistic regression analysis showed that the most important factors associated with the development of pneumonia were the presence of an underlying disease (p=0.021, odds ratio (OR) 3.08) and the carriage of at least one −238 A allele (p=0.041, OR 3.74). Gene transcripts of the TNF gene were greater among non-carriers of the −238 A allele than among carriers of the −238 A allele.Conclusions: The −238 A SNP allele of the TNF gene imposes on the course of 2009 H1N1 virus infection and is an independent risk factor for pneumonia.</description><dc:title>Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection - Corrected Proof</dc:title><dc:creator>Anastasia Antonopoulou, Fotini Baziaka, Thomas Tsaganos, Maria Raftogiannis, Pantelis Koutoukas, Aikaterini Spyridaki, Maria Mouktaroudi, Antigone Kotsaki, Athina Savva, Marianna Georgitsi, Evangelos J. Giamarellos-Bourboulis</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.012</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-24</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-24</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002463/abstract?rss=yes"><title>A case of rickettsialpox in Northern Europe - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002463/abstract?rss=yes</link><description>Summary: We report the first case of rickettsialpox caused by Rickettsia akari in the Netherlands. The diagnosis was suspected based on clinical grounds and was confirmed by Western blot analysis with cross-adsorption. Because the arthropod vector (Liponyssoides sanguineus) is ubiquitous, we suspect that the disease is under-diagnosed in non-endemic areas.</description><dc:title>A case of rickettsialpox in Northern Europe - Corrected Proof</dc:title><dc:creator>Aurélie Renvoisé, Jan W. van’t Wout, Jan-Gerrit van der Schroeff, Matthias F. Beersma, Didier Raoult</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.009</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-18</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-18</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002475/abstract?rss=yes"><title>Impact of a national hospital evaluation program using clinical performance indicators on the use of surgical antibiotic prophylaxis in Korea - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002475/abstract?rss=yes</link><description>Summary: Objectives: Clinical performance measurement in surgical antibiotic prophylaxis (SAP) was implemented as part of a national hospital evaluation program (NHEP) in Korea in 2007. This study investigated changes in SAP quality before and after the implementation of clinical performance measurement.Methods: The medical records of patients who underwent three types of surgery that were included for assessment in the NHEP (NHEP surgery) – arthroplasty, gastrectomy, and hysterectomy – and two other types of non-NHEP assessment surgery – craniotomy and spine surgery (non-NHEP surgery) – at six hospitals, from August to October in 2006–2008, were retrospectively reviewed. Three clinical indicators of SAP (antibiotic selection, timing of administration of the first dose, and duration) and the development of surgical site infections (SSIs) were compared before and after implementation.Results: A total of 1949 patients were enrolled: 356 arthroplasty, 273 gastrectomy, 615 hysterectomy, 168 craniotomy, and 537 spinal surgery. There were no significant changes in age, gender, wound class, or ASA score for each surgery during the study period. From 2007, SAP quality was significantly improved in NHEP surgery for the three clinical indicators. The timing of administration of the first dose was most markedly improved. SAP quality was also improved in non-NHEP surgery, but not as much as in NHEP surgery. Changes in the SSI rates for each surgery were not significant.Conclusions: Hospital evaluation using clinical performance indicators can considerably improve the use of SAP. Further studies are warranted to investigate whether this hospital evaluation will decrease the development of SSIs.</description><dc:title>Impact of a national hospital evaluation program using clinical performance indicators on the use of surgical antibiotic prophylaxis in Korea - Corrected Proof</dc:title><dc:creator>Eu Suk Kim, Sang-Won Park, Chang-Seop Lee, Yee Gyung Kwak, Chisook Moon, Baek-Nam Kim</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.010</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-16</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-16</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002487/abstract?rss=yes"><title>hsp65 PCR-restriction analysis (PRA) with capillary electrophoresis for species identification and differentiation of Mycobacterium kansasii and Mycobacterium chelonae–Mycobacterium abscessus group - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002487/abstract?rss=yes</link><description>Summary: Objectives: The aim of the present study was to identify and differentiate Mycobacterium kansasii and Mycobacterium chelonae–Mycobacterium abscessus group strains isolated from clinical and environmental sources in different countries.Methods: PCR-restriction analysis of the hsp65 gene (PRA) with automated capillary electrophoresis was applied to the isolates previously identified by conventional biochemical testing and the molecular INNO-LiPA MYCOBACTERIA assay.Results: PRA performed very well in comparison with the two other methods (96.4% concordance). Among 27M. kansasii isolates, this method detected five genetic types, of which type 1 represented the most common clinical isolate, as it is worldwide. PRA differentiated 29M. chelonae–M. abscessus group isolates into Mycobacterium immunogenum type 2 (n=13), M. chelonae (n=12), and M. abscessus types 1 (n=1) and 2 (n=1). M. immunogenum was the most frequent (69%) isolate from humans, but only one of 11 cases was clinically significant. M. chelonae was the most commonly (83%) recovered from water. PRA also identified two isolates with hsp65 alleles representing previously unreported patterns.Conclusions: PRA based on automated capillary electrophoresis is a rapid, simple, and reliable method for the identification and differentiation of both clinically relevant and environmental isolates of M. kansasii and M. chelonae–M. abscessus group.</description><dc:title>hsp65 PCR-restriction analysis (PRA) with capillary electrophoresis for species identification and differentiation of Mycobacterium kansasii and Mycobacterium chelonae–Mycobacterium abscessus group - Corrected Proof</dc:title><dc:creator>Anna Sajduda, Anandi Martin, Françoise Portaels, Juan Carlos Palomino</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.011</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-13</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-13</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002451/abstract?rss=yes"><title>Group B Streptococcus infections in non-pregnant adults: the role of immunosuppression - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002451/abstract?rss=yes</link><description>Summary: Background: Group B Streptococcus (GBS) is a known causative pathogen of neonatal sepsis, but the epidemiology in non-pregnant adults is less studied.Methods: Retrospective case–control and cohort analyses of risk factors and outcomes of GBS infections among non-pregnant adults were conducted at the Detroit Medical Center from January 2005 to May 2010. Uninfected controls were matched to cases in a 3:1 ratio. Data were obtained from charts and pharmacy records. Identification of the bacteria and antimicrobial susceptibility testing were determined by MicroScan. Cox regression was used for matched multivariate analyses.Results: Thirty-two patients with GBS infections were identified and were matched and compared to 96 controls. Compared to controls, patients with GBS infection were significantly younger. Immunosuppression, attributable mainly to neutropenia and recent use of glucocorticoids, was an independent predictor for GBS infection (odds ratio 2.7, p=0.03). Nine (28%) of the patients with GBS infection had bacteriological failure despite the administration of appropriate antimicrobial therapy. Of the 10 patients with bloodstream infections (BSI), three had endocarditis and four had central nervous system (CNS) infections. During the study period the incidence of infections decreased, but the rates of resistance to erythromycin and clindamycin increased.Conclusions: GBS, previously considered a genitourinary pathogen, has emerged as a non-nosocomial opportunistic pathogen causing BSI, endocarditis, and CNS infections. Immunosuppression, particularly transient immunosuppressed states, was an independent predictor for GBS BSI. Resistance rates to macrolides and clindamycin continue to increase, and should be closely monitored.</description><dc:title>Group B Streptococcus infections in non-pregnant adults: the role of immunosuppression - Corrected Proof</dc:title><dc:creator>Bharath Sunkara, Suchitha Bheemreddy, Bibi Lorber, Paul R. Lephart, Kayoko Hayakawa, Jack D. Sobel, Keith S. Kaye, Dror Marchaim</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.008</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-12</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-12</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002396/abstract?rss=yes"><title>Trends in early and late diagnosis of HIV-1 infections in Tokyoites from 2002 to 2010 - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002396/abstract?rss=yes</link><description>Summary: Objective: The objective of this study was to delineate the trends in early and late diagnosis of HIV-1 infection in newly diagnosed Tokyoites.Methods: The BED assay was used to identify cases diagnosed at an early stage of infection. BED-positive non-AIDS cases with a CD4 cell count ≥200/μl were defined as cases with recent infection. The rates of AIDS and recent infection in 809 newly diagnosed Tokyoites during 2002–2010 were analyzed.Results: The AIDS rate was 22.5%. AIDS patients were older (40.4 years) than non-AIDS patients (35.0 years), and a smaller proportion were men who have sex with men (MSM) in AIDS patients (81.7%) than in non-AIDS patients (89.9%). The AIDS rate was persistently lower (≤14.3%) in ≤29-year-old than in ≥30-year-old MSM. The rate of recent infection was 24.4%. Individuals with recent infection (33.0 years old) were younger than the others (37.2 years). The rate of recent infection was lower (≤18.5%) in MSM aged ≥40 years than in those aged ≤39 years during the study period, except for 2007 and 2008.Conclusions: Younger MSM Tokyoites appear to be aware of the risk of their sexual behavior, sufficient to take voluntary HIV testing repeatedly, resulting in early diagnosis. Older MSM did not take HIV testing frequently enough and may be a good target for campaigns promoting testing.</description><dc:title>Trends in early and late diagnosis of HIV-1 infections in Tokyoites from 2002 to 2010 - Corrected Proof</dc:title><dc:creator>Tsunefusa Hayashida, Hiroyuki Gatanaga, Yukiko Takahashi, Fujie Negishi, Yoshimi Kikuchi, Shinichi Oka</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.003</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-11</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-11</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS120197121100244X/abstract?rss=yes"><title>Emphysematous osteomyelitis: a case report and review of the literature - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS120197121100244X/abstract?rss=yes</link><description>Summary: We report the case of a 15-year-old girl with pelvic and sacral emphysematous osteomyelitis caused by Fusobacterium necrophorum. This infection was cured following four surgical procedures and 4 weeks of intravenous then 4 weeks of oral antibiotics. We review our case alongside the 24 previously reported cases of emphysematous osteomyelitis in the literature. The 25 cases include 15 monomicrobial and 10 polymicrobial infections. The causative organism(s) in all but three cases included an anaerobe or a member of the Enterobacteriaceae family. A significant underlying comorbidity was reported in 18 cases. At least 15 cases required one or more surgical procedures. There was a significant associated mortality with eight (32%) patients dying in hospital at 7 to 56 days after the diagnosis of emphysematous osteomyelitis.</description><dc:title>Emphysematous osteomyelitis: a case report and review of the literature - Corrected Proof</dc:title><dc:creator>Christopher Luey, Debbie Tooley, Simon Briggs</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.007</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-09</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-09</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002438/abstract?rss=yes"><title>Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002438/abstract?rss=yes</link><description>Summary: Objectives: The aim of the current study was to compare the effectiveness of adefovir dipivoxil (ADV) monotherapy with that of combination ADV and lamivudine (LAM) therapy in the treatment of LAM-resistant chronic hepatitis B (CHB).Methods: Publications on the effectiveness of ADV monotherapy versus the combination of ADV and LAM therapy for the treatment of LAM-resistant CHB were identified by a search (up to year 2010) of the PubMed, HealthStar, ScienceDirect, and VIP databases. Biochemical response data (alanine aminotransferase normalization rate) and virological response data (serum hepatitis B virus DNA undetectable rate) were extracted and combined to obtain an integrated result.Results: The literature search yielded 11 articles, six of which reported randomized controlled trials; the remaining five reported prospective cohort studies. The summary odds ratio (OR) values of the biochemical response at 3, 6, 12, and &gt;12 months were 1.60 (p=0.06), 1.30 (p=0.18), 1.77 (p=0.008), and 3.35 (p&lt;0.00001), respectively. The summary OR values of the virological response at 3, 6, 12, and &gt;12 months were 1.46 (p=0.21), 1.68 (p=0.04), 1.16 (p=0.54), and 1.87 (p=0.01), respectively.Conclusions: The effectiveness of the combination therapy was not obviously predominant over the monotherapy in short duration therapies; however, the combination therapy had a great advantage over monotherapy in both biochemical and virological response when the therapy duration was prolonged to &gt;12 months.</description><dc:title>Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B - Corrected Proof</dc:title><dc:creator>YongFa Chen, Ting Ju</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.006</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-06</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-06</prism:publicationDate><prism:section>REVIEW</prism:section></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002414/abstract?rss=yes"><title>Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999–2010 - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002414/abstract?rss=yes</link><description>Summary: Objective: To compare the prevalence, phenotypes, and genes responsible for erythromycin resistance among Streptococcus pyogenes isolates from Mexico and the USA.Methods: Eighty-nine invasive and 378 non-invasive isolates from Mexico, plus 148 invasive, 21 non-invasive, and five unclassified isolates from the USA were studied. Susceptibilities to penicillin, erythromycin, clindamycin, ceftriaxone, and vancomycin were evaluated according to Clinical and Laboratory Standards Institute (CLSI) standards. Phenotypes of erythromycin resistance were identified by triple disk test, and screening for mefA, ermTR, and ermB genes was carried out by PCR.Results: All isolates were susceptible to penicillin, ceftriaxone, and vancomycin. Erythromycin resistance was found in 4.9% of Mexican strains and 5.2% of USA strains. Phenotypes in Mexican strains were 95% M and 5% cMLS; in strains from the USA, phenotypes were 33.3% iMLS, 33.3% iMLS-D, and 33.3% M. Erythromycin resistance genes in strains from Mexico were mefA (95%) and ermB (5%); USA strains harbored ermTR (56%), mefA (33%), and none (11%). In Mexico, all erythromycin-resistant strains were non-invasive, whereas 89% of strains from the USA were invasive.Conclusions: Erythromycin resistance continues to exist at low levels in both Mexico and the USA, although the genetic mechanisms responsible differ between the two nations. These genetic differences may be related to the invasive character of the S. pyogenes isolated.</description><dc:title>Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999–2010 - Corrected Proof</dc:title><dc:creator>Alberto Villaseñor-Sierra, Eva Katahira, Abril N. Jaramillo-Valdivia, María de los Angeles Barajas-García, Amy Bryant, Rayo Morfín-Otero, Francisco Márquez-Díaz, Juan Carlos Tinoco, José Sánchez-Corona, Dennis L. Stevens</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.005</dc:identifier><dc:source>International Journal of Infectious Diseases (2012)</dc:source><dc:date>2012-01-04</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2012-01-04</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002372/abstract?rss=yes"><title>Epidemiological analysis of measles and evaluation of measles surveillance system performance in Iraq, 2005–2010 - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002372/abstract?rss=yes</link><description>Summary: Objectives: The objectives of this study were to identify the risk factors for measles and low vaccination rates, to evaluate the performance of surveillance, and to calculate vaccine effectiveness and failure in Iraq for the years 2005 to 2010.Methods: Logistic regression was used on measles surveillance data from Iraq obtained during the period 1 January 2005 to 31 December 2010; adjusted odds ratios were calculated. The performance of surveillance was evaluated according to World Health Organization (WHO) guidelines.Results: Of 18 746 suspected cases, a measles diagnosis was made for 81.4%. Children aged 1–5 years were the most affected (&gt;48%). The odds of measles were significantly higher in the central and southern provinces than in the northern provinces. Those vaccinated with at least one dose of measles-containing vaccine had a 3.7-times lower risk of contracting measles than those who were not vaccinated. Lower odds of vaccination were noted for adults aged 18 years and older and those living in central and southern provinces, as well as those living outside the capital city of a province. Three WHO performance indicators were lower than the recommended cut-off levels. A vaccine failure rate of 66.1% and effectiveness of 90.03% were estimated.Conclusions: Measles continues to be an important cause of morbidity in Iraq. Improvements in vaccine coverage, proper vaccine handling, and prompt reporting of suspected cases are all necessary to eliminate measles from Iraq.</description><dc:title>Epidemiological analysis of measles and evaluation of measles surveillance system performance in Iraq, 2005–2010 - Corrected Proof</dc:title><dc:creator>Jagar Jasem, Kawa Marof, Adnan Nawar, K.M. Monirul Islam</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.002</dc:identifier><dc:source>International Journal of Infectious Diseases (2011)</dc:source><dc:date>2011-12-22</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2011-12-22</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971211002207/abstract?rss=yes"><title>Microbiology and surgical indicators of necrotizing fasciitis in a tertiary hospital of southwest Taiwan - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971211002207/abstract?rss=yes</link><description>Summary: Background: Necrotizing fasciitis is a true surgical emergency. This study was undertaken to determine whether clinical indicators could be used to initiate early surgery, and to compare the characteristics observed on initial examination of necrotizing fasciitis in patients who died and those who survived.Methods: We retrospectively reviewed the medical records of 143 patients with surgically confirmed necrotizing fasciitis of the extremities over a period of 3.5 years at a tertiary hospital of southwest Taiwan. Differences in mortality, patient characteristics, laboratory findings, and hospital course were compared between patients who died and those who survived, and between patients with Gram-positive infections and those with Gram-negative infections.Results: A patient with a fungal infection died. Nine of the 58 patients in the Gram-positive group (15.5%) and 12 of the 60 cases in the Gram-negative group (20%) died. Hence a total of 22 patients died, giving a mortality rate of 15.4%. Hypotension, lower counts of total and segmented leukocytes, higher counts of banded leukocytes, and lower levels of serum albumin were significantly associated with mortality. Monomicrobial infections had a stake of 70.6%, and Vibrio spp were the predominant causative agents (26.6%).Conclusions: Hypotensive shock, severe hypoalbuminemia, and increased counts of banded leukocytes can be considered the clinical and laboratory risk indicators to initiate early surgery and to predict mortality for all types of necrotizing fasciitis. The clinical characteristics of Gram-negative infections were more fulminant than those of Gram-positive infections.</description><dc:title>Microbiology and surgical indicators of necrotizing fasciitis in a tertiary hospital of southwest Taiwan - Corrected Proof</dc:title><dc:creator>Yao-Hung Tsai, Kuo-Chin Huang, Shih-Hsun Shen, Wei-Hsiu Hsu, Kuo-Ti Peng, Tsung-Jen Huang</dc:creator><dc:identifier>10.1016/j.ijid.2011.11.001</dc:identifier><dc:source>International Journal of Infectious Diseases (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate></item><item rdf:about="http://www.ijidonline.com/article/PIIS1201971204000438/abstract?rss=yes"><title>WITHDRAWN: Transplant - Corrected Proof</title><link>http://www.ijidonline.com/article/PIIS1201971204000438/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: Transplant - Corrected Proof</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/j.ijid.2004.04.005</dc:identifier><dc:source>International Journal of Infectious Diseases (2009)</dc:source><dc:date>2009-03-27</dc:date><prism:publicationName>International Journal of Infectious Diseases</prism:publicationName><prism:publicationDate>2009-03-27</prism:publicationDate></item></rdf:RDF>
